Banque Cantonale Vaudoise Neurocrine Biosciences Inc Transaction History

Banque Cantonale Vaudoise

$2.43 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$130.86 - $143.19 $58,363 - $63,862	-446 Reduced 37.61%	740 $102,000
Q1 2024 Apr 10, 2024	BUY	$130.4 - $143.74 $102,624 - $113,123	787 Added 197.24%	1,186 $164,000
Q4 2023 Feb 07, 2024	SELL	$106.07 - $132.76 $137,360 - $171,924	-1,295 Reduced 76.45%	399 $53,000
Q3 2023 Nov 08, 2023	SELL	$94.02 - $117.1 $254,324 - $316,755	-2,705 Reduced 61.49%	1,694 $191,000
Q2 2023 Aug 09, 2023	SELL	$89.53 - $104.87 $307,983 - $360,752	-3,440 Reduced 43.88%	4,399 $415,000
Q1 2023 Apr 20, 2023	BUY	$94.11 - $123.02 $319,974 - $418,268	3,400 Added 76.59%	7,839 $793,000
Q4 2022 Feb 10, 2023	SELL	$106.72 - $127.06 $5,869 - $6,988	-55 Reduced 1.22%	4,439 $530,000
Q3 2022 Oct 17, 2022	BUY	$92.03 - $107.81 $5,889 - $6,899	64 Added 1.44%	4,494 $476,000
Q2 2022 Aug 02, 2022	SELL	$75.79 - $100.07 $884,469 - $1.17 Million	-11,670 Reduced 72.48%	4,430 $432,000
Q1 2022 May 09, 2022	BUY	$72.45 - $94.81 $840,420 - $1.1 Million	11,600 Added 257.78%	16,100 $1.51 Million
Q3 2021 Oct 29, 2021	SELL	$86.18 - $99.03 $53,345 - $61,299	-619 Reduced 12.09%	4,500 $432,000
Q2 2021 Aug 11, 2021	BUY	$89.43 - $102.27 $330,891 - $378,399	3,700 Added 260.75%	5,119 $498,000
Q1 2021 May 11, 2021	BUY	$87.57 - $119.4 $2,627 - $3,582	30 Added 2.16%	1,419 $137,000
Q4 2020 Feb 05, 2021	BUY	$86.91 - $108.33 $51,189 - $63,806	589 Added 73.63%	1,389 $133,000
Q3 2020 Oct 30, 2020	SELL	$96.16 - $135.15 $144,240 - $202,725	-1,500 Reduced 65.22%	800 $76,000
Q2 2020 Jul 22, 2020	BUY	$85.09 - $130.36 $195,707 - $299,828	2,300 New	2,300 $280,000
Q1 2020 May 14, 2020	SELL	$75.11 - $113.76 $69,551 - $105,341	-926 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$86.8 - $118.57 $80,376 - $109,795	926 New	926 $100,000

Others Institutions Holding NBIX

# of Institutions

635

Shares Held

93.5M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$2.09 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.48 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$760 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$380 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$275 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Account